GlaxoSmithKline launched its cervical cancer vaccine Cervarix in the UK on Tuesday, pricing it at about the same level as rival treatment, Merck’s Gardasil.

Shire has amassed a 560-person sales force in advance of its Monday launch of new attention deficit hyperactivity drug Vyvanse.

GlaxoSmithKline continues to prepare for the rollout of its new OTC diet pill Alli.

Bradley Pharmaceuticals is hiring about 60 reps as it gears up to launch Elestrin, a low-dose estrogen gel for treating the symptoms of menopause.

The FDA was petitioned to approve OTC switches for Allegra (fexofenadine), Allegra D 12-hour and 24-hour (fexofenadine with pseudophedrine), and Zyrtec (cetirizine) and Zyrtec D (cetirizine with pseudophedrine).

Lilly launched new Cymbalta work for depression and diabetic nerve pain in April.

The FDA launched a Web site warning of the dangers of purchasing Roche’s acne drug Accutane (isotretinoin) or any of its generic equivalents over the Internet.

Kinetic, the outdoor media agency, has launched a healthcare practice.

Skyscape has launched Skyscape CME 360 to help docs keep up with the latest medical info.

Wunderman has been chosen to launch a consumer campaign for AstraZeneca’s breast cancer treatment Faslodex.